Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis

Current Drug Research Reviews
Brienna N MeffertAdrienne J Heinz

Abstract

The United States has recently experienced extensive changes in state policy regarding the use of cannabis for recreational and medicinal purposes. Despite its rapidly increasing accessibility and social acceptance, there is a striking dearth of research on cannabis as a treatment for medical and psychological conditions. Research on cannabis is difficult to conduct as it is classified as a schedule I drug with high potential for abuse and currently no accepted medical use in treatment. As a result, no standard dosing procedures exist and the lack of conclusive scientific evidence has left clinical providers without evidence-based guidelines about if, when, and how to guide clients on using cannabis safely. To (1) provide critical psychoeducational information about cannabis and cannabis problems to guide client-provider conversations about cannabis use and (2) describe common clinical concerns around cannabis use, highlight special considerations for vulnerable populations, and review harm reduction techniques and practical resources that may help clinicians and their clients navigate safer cannabis use. The removal of regulatory barriers would enable researchers to address key public health questions about the potential thera...Continue Reading

References

Jul 1, 1974·Psychological Bulletin·L L Miller, W G Drew
Aug 1, 1981·Journal of Clinical Pharmacology·L F Fabre, D McLendon
Aug 1, 1981·Journal of Clinical Pharmacology·L E HollisterS Agurell
Nov 1, 1996·Addictive Behaviors·G A Marlatt
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
May 15, 2004·AIDS Patient Care and STDs·Michelle D FurlerReina Bendayan
Oct 4, 2005·Life Sciences·Mahmoud A Elsohly, Desmond Slade
Apr 26, 2006·Journal of Pharmaceutical Sciences·Arno HazekampRob Verpoorte
Aug 8, 2007·Annals of Internal Medicine·Christine T CigolleCaroline S Blaum
Aug 23, 2007·Chemistry & Biodiversity·Marilyn A Huestis
May 21, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Dan G Blazer, Li-Tzy Wu
Nov 20, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sagnik BhattacharyyaPhilip K McGuire
Mar 30, 2010·Drug and Alcohol Dependence·Simon J AdamsonJ Douglas Sellman
Feb 11, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mateus M BergamaschiJosé Alexandre S Crippa
Jun 1, 2004·American Journal of Botany·Karl W Hillig, Paul G Mahlberg
Jun 15, 2011·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Jennifer K ManuelJohn W Finney
Jul 14, 2011·British Journal of Pharmacology·Ethan B Russo
Aug 24, 2011·Journal of Psychoactive Drugs·Craig ReinarmanTom Heddleston
Apr 10, 2012·The Journal of Pain : Official Journal of the American Pain Society·Russell K PortenoyMarie T Fallon
May 9, 2012·Psychological Services·Marcel O Bonn-MillerJodie A Trafton
May 24, 2012·Journal of General Internal Medicine·Glyn ElwynMichael Barry
Jul 17, 2012·Neuropharmacology·Christine A RabinakK Luan Phan
Nov 28, 2012·European Journal of Clinical Pharmacology·C G StottG W Guy
Feb 7, 2013·Pharmacotherapy·Laura M BorgeltGeorge S Wang
Jul 9, 2013·Current Pharmaceutical Design·Christine A Rabinak, K Luan Phan
Oct 15, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Stéphanie BaggioGerhard Gmel
Jun 5, 2014·The New England Journal of Medicine·Nora D VolkowSusan R B Weiss
Jun 16, 2014·Addictive Behaviors·Mallory Loflin, Mitch Earleywine
Aug 27, 2014·JAMA Internal Medicine·Marcus A BachhuberColleen L Barry
Oct 24, 2014·Analytical and Bioanalytical Chemistry·Oier Aizpurua-OlaizolaAresatz Usobiaga
Feb 24, 2015·Stroke; a Journal of Cerebral Circulation·Daniel G Hackam
Mar 20, 2015·Nature·Sara Reardon
Jun 24, 2015·JAMA : the Journal of the American Medical Association·Ryan VandreyMarcel O Bonn-Miller
Jul 8, 2015·Addictive Behaviors·Katherine A BelendiukMarcel O Bonn-Miller
Aug 20, 2015·The Australian and New Zealand Journal of Psychiatry·Hannah MylesMatthew Large
Sep 5, 2015·The American Journal on Addictions·Peter Roy-ByrneRichard Ries
Oct 31, 2015·European Journal of Pain : EJP·D C HammellK N Westlund
Feb 3, 2016·Journal of Natural Products·Oier Aizpurua-OlaizolaAresatz Usobiaga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved